Lactobacillus therapy reduces heavy drinking in patients with alcohol-associated hepatitis

Lactobacillus therapy reduces heavy drinking in patients with alcohol-associated hepatitis

A 6-month Lactobacillus rhamnosus GG treatment for moderate alcohol-associated hepatitis correlated with a decrease in heavy drinking levels to the social drinking or abstinence levels, according to a presentation.“Counseling therapy in patients, particularly in the placebo treated patients with alcohol use disorder, seems to provide some benefit in reducing drinking levels,” Vatsalya Vatsalya, MD, PhD, MS, MSc, instructor in medicine at the University of Louisville, Kentucky, said during the presentation at The Liver Meeting Digital Experience. “[Lactobacillus rhamnosus GGRead More

Share on facebook
Share on twitter
Share on linkedin